Care

Private rheumatologist Dr Anandita Santosa in Singapore notes how current AI in healthcare priorities practically leave autoimmune and rheumatic diseases behind and shares what can be done to build a more comprehensive AI-driven preventive care ecosystem.

Clinician innovators across the region see the next phase of healthcare AI focusing on trust and responsible adoption after a year of rapid experimentation.

Predictions from Australia to Southeast Asia highlight where AI, telehealth, and platform consolidation are headed next.

Eitan Okun, head of the Paul Feder Laboratory for Alzheimer's Disease Research at Bar-Ilan University, studies aging individuals and he is currently evaluating the link between maternal cognitive decline and pregnancy with a Down syndrome fetus.

The company, which made the announcement at the JPM Healthcare Conference in San Francisco, will use the funds to expand its AI-powered Halo Intelligence platform.

The digital pharmacy will sell the newly FDA-approved weight-loss pill nationwide, allowing patients to pay through their insurance or in cash.

Ceribell received breakthrough device designation for its LVO stroke detection monitor, and Naox Technologies secured 510(k) clearance for its in-ear EEG device.

Sutter Health's Dr. Richard Milani and Epic's Trevor Berceau talk about Sutter's chronic care program, which integrates readings from remote monitoring devices into the EHR to give doctors continuous insight into patients' conditions.

A Mesothelioma Center report finds that more than half of Americans use ChatGPT for medical symptoms, widening a gap between patient reliance on AI and clinician concerns.

The collaboration will allow patients considering the oral GLP-1 therapy to access metabolic care through knownwell’s hybrid model.